Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Madrigal Pharmaceuticals (MDGL) over the last 16 years, with Dec 2024 value amounting to $1.1 million.

  • Madrigal Pharmaceuticals' Depreciation & Amortization (CF) rose 20.13% to $358,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 68.80%. This contributed to the annual value of $1.1 million for FY2024, which is 107.97% up from last year.
  • According to the latest figures from FY2024, Madrigal Pharmaceuticals' Depreciation & Amortization (CF) is $1.1 million, which was up 107.97% from $527,000 recorded in FY2023.
  • In the past 5 years, Madrigal Pharmaceuticals' Depreciation & Amortization (CF) registered a high of $1.1 million during FY2024, and its lowest value of $405,000 during FY2021.
  • For the 3-year period, Madrigal Pharmaceuticals' Depreciation & Amortization (CF) averaged around $696,667, with its median value being $527,000 (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first spiked by 320.54% in 2020, then fell by 14.01% in 2021.
  • Over the past 5 years, Madrigal Pharmaceuticals' Depreciation & Amortization (CF) (Yearly) stood at $471,000 in 2020, then dropped by 14.01% to $405,000 in 2021, then increased by 15.31% to $467,000 in 2022, then climbed by 12.85% to $527,000 in 2023, then surged by 107.97% to $1.1 million in 2024.